List of Certificates of Suitability (CEPs) for r1_cep_2001_367___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-367 - Rev 05 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl

score 20 · Accepted Answer

Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

One of their significant offerings is Amoxicillin trihydrate, Almería, Spain, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-367 - Rev 05

This Chemical Type CEP, issued on March 21, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 260 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for r1_cep_2001_367___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Centrient Pharmaceuticals

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

2 INTERVIEW #SpeakPharma

1 VLOG #PharmaReel

19 CORPORATE CONTENT #SupplierSpotlight

73 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

KEY PRODUCTS

INSPECTIONS & REGISTRATIONS

Filters

R1-CEP 2001-367 - Rev 05

Valid

Chemical

2019-03-21

260

01

Looking for Certificates of Suitability (CEPs) for R1-CEP 2001-367 - Rev 05 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl